Minsa Lifescience Private Limited - Due diligence report

A 360° intelligence report on Minsa Lifescience Private Limited: trust score, financial health, credit view, compliance, directors, growth a…

2016-09-29 Mumbai, Maharashtra Strike Off Unlisted Active Compliant
Share
View plans
ML Minsa Lifescience Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Minsa Lifescience Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
45/100
Trust Score
Caution Indicated

Minsa Lifescience Private Limited is assessed as Caution Indicated with a Trust Score of 45/100. Minsa Lifescience Private Limited is a private limited indian non-government company incorporated in 2016, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 28 Jun 2026 from the latest processed filings. Minsa Lifescience Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
45/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
25/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ABHISHEK RAJKUMAR SINGH 01234567 Director 01/04/2018 6 yrs Approved
ANUJKUMAR GIRISHCHANDRA SHARMA 01234567 Director 01/04/2018 6 yrs Approved
AJAY SUNIL SAO 01234567 Director 01/04/2018 6 yrs Approved
MOHAMMAD AKRAM MOHAMMAD VAKIL SHAIKH 01234567 Director 01/04/2018 6 yrs Approved
SACHIN LALTARAM PAL 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 25
Growth signals & trust indicators
Latest year revenue grew 38%.
Asset base grew 1.42 - capacity expansion.
Operating for 9 years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 2.1x in a year.
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence33/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment35/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view46/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2023
Last AGM held
Annual general meeting
31 Mar 2023
Latest balance sheet
Filed with ROC
30 Sep 2019
Director ceased
ABHISHEK RAJKUMAR SINGH
Director ceased
ANUJKUMAR GIRISHCHANDRA SHARMA
Director ceased
AJAY SUNIL SAO
16 Jan 2019
Director appointed
ABHISHEK RAJKUMAR SINGH (Director)
Director appointed
ANUJKUMAR GIRISHCHANDRA SHARMA (Director)
Director appointed
AJAY SUNIL SAO (Director)
29 Sep 2016
Incorporated
Registered with Roc Mumbai
Director appointed
MOHAMMAD AKRAM MOHAMMAD VAKIL SHAIKH (Director)
Director appointed
SACHIN LALTARAM PAL (Director)
10

Key Observations

Auto-generated from the data above
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2018 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Blg Pharma Private Limited U74999UP2018PTC104149 Gorakhpur, Uttar Pradesh, India
Arcorp Pharmaceuticals Private Limited U24239MP2019PTC050263 Bhopal, Madhya Pradesh, India
Exprohelp Technosoft Private Limited U72300UP2014PTC065510 Lucknow, Uttar Pradesh, India
Austerity Healthcare Private Limited U85190UP2017PTC098957 Noida, Uttar Pradesh, India
Arolin Pharma Private Limited U51909WB2018PTC226696 North 24 Paragnas, West Bengal, India
Qudos Life Sciences Private Limited U74999DL2018PTC332189 Delhi, Delhi, India
Adlife Healthcare Private Limited U24230MH2005PTC154674 Mumbai, Maharashtra, India
Shoreline Enterprises Private Limited U01100RJ2018PTC062208 Pali, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Minsa Lifescience Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Minsa Lifescience Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Minsa Lifescience Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 45/100, distress signals and MSME payment-delay disclosures - know whether Minsa Lifescience Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Minsa Lifescience Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Minsa Lifescience Private Limited an active company?

Minsa Lifescience Private Limited has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).

Is Minsa Lifescience Private Limited financially healthy?

Minsa Lifescience Private Limited has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Minsa Lifescience Private Limited?

Its overall Trust Score is 45/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Minsa Lifescience Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Minsa Lifescience Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Minsa Lifescience Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Minsa Lifescience Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.